Filing Flows › Intelligent Bio Solutions (INBS) › Q3 FY26 › vs Q2 FY26
Intelligent Bio Solutions (INBS) Q3 FY26 vs Q2 FY26 (quarter over quarter)
Intelligent Bio Solutions's revenue rose $164K (+18%) from $897K in Q2 FY26 to $1.1M in Q3 FY26. The biggest changes: Sales of goods - cartridges +$187K (+36%); Sales of goods - readers −$107K (-43%); Other sales - accessories +$84K (+63%).
Intelligent Bio Solutions, Q3 FY26: revenue $1.1M (+18% year over year), operating margin -277.8%, net loss $2.9M, operating cash flow −$4.3M. The chart draws each line against Q2 FY26, the increases inside each band.
Every line
| Line | Q3 FY26 | Q2 FY26 | Change | % |
|---|---|---|---|---|
| Sales of goods - cartridges | $704K | $517K | $187K | +36% |
| Other sales - accessories | $218K | $134K | $84K | +63% |
| Sales of goods - readers | $139K | $247K | −$107K | -43% |
| Revenue | $1.1M | $897K | $164K | +18% |
| Other income, net | $77K | −$51K | $128K | — |
| Net loss | $2.9M | $2.7M | $183K | +7% |
| Costs & expenses | $4.0M | $3.6M | $425K | +12% |
| Operating costs | $4.0M | $3.5M | $475K | +13% |
| Cost of revenue | $525K | $437K | $88K | +20% |
| SG&A | $2.5M | $2.3M | $122K | +5% |
| Other operating costs | $1.0M | $758K | $265K | +35% |
| Operating cash sources | $4.6M | $2.0M | $2.7M | +137% |
| Depreciation & amortization | $290K | $327K | −$37K | -11% |
| Share-based compensation | $24K | $62K | −$37K | -61% |
| Cash used in operations | $4.3M | $1.6M | $2.8M | +176% |
| Net loss absorbed | $2.9M | $2.7M | $183K | +7% |
| Working capital & other | $1.8M | −$730K | $2.5M | — |
Questions
How much did Intelligent Bio Solutions's revenue grow quarter over quarter in Q3 FY26?
Intelligent Bio Solutions's revenue rose $164K (+18%) from $897K in Q2 FY26 to $1.1M in Q3 FY26.
What drove Intelligent Bio Solutions's revenue change in Q3 FY26?
Sales of goods - cartridges +$187K (+36%); Sales of goods - readers −$107K (-43%); Other sales - accessories +$84K (+63%).